drugset / Trial / NCT05573672
Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder
Phase 2
Completed
50 enrolled
The Canadian College of Naturopathic Medicine
AquaOmega · collabEkhagastiftelsen · collabLipid Analytical Laboratories Inc · collabMassachusetts General Hospital · collabMcGill University · collabMitacs · collabNetherlands Open University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will assess the feasibility and acceptability of a combination intervention including dietary counselling and omega-3 fatty acid supplementation among women with generalized anxiety disorder. It will be randomized and wait-list controlled with 25 participants completing the 12-week intervention immediately and the other 25 participants completing the intervention after a 12-week wait period.
Timeline
- Start
- 2022-08-12
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
Publications
- Aucoin M, LaChance L, van der Wurff I, McLaren M, Monteiro S, Miller S, Jenkins A, Sabri E, Cooley K. Dietary counseling plus omega-3 supplementation in the treatment of generalized anxiety disorder: results of a randomized wait-list controlled pilot trial (the 'EASe-GAD Trial'). Nutr Neurosci. 2025 Jun;28(6):635-648. doi: 10.1080/1028415X.2024.2403901. Epub 2024 Sep 24.
- Aucoin M, LaChance L, van der Wurff I, Miller S, Naidoo U, Jenkins A, Cooley K. Dietary counselling plus omega-3 supplementation in the treatment of generalized anxiety disorder: protocol for a randomized wait-list controlled pilot trial (the "EASe-GAD Trial"). Pilot Feasibility Stud. 2023 Nov 10;9(1):186. doi: 10.1186/s40814-023-01414-y.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omega-3 fatty acids | Unknown | 3456 mg | — |